Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction

IMPORTANCE: Sacubitril-valsartan use reduces mortality and hospitalizations compared with enalapril among patients with chronic heart failure with reduced ejection fraction (HFrEF); however, the cost-effectiveness of these treatments when initiated during hospitalization for HF is unknown. OBJECTIVE...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA Cardiol
Asıl Yazarlar: Gaziano, Thomas A., Fonarow, Gregg C., Velazquez, Eric J., Morrow, David A., Braunwald, Eugene, Solomon, Scott D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Medical Association 2020
Konular:
Original Investigation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675099/
https://ncbi.nlm.nih.gov/pubmed/32785628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.2822
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller